Alerts will be sent to your verified email
Verify Email
VILINBIO
|
Vilin Bio Med
|
Chandra Bhagat Pharm
|
Omkar Pharmachem
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.09 % | 3.03 % | 2.2 % |
|
5yr average Equity Multiplier
|
1.6 | 2.92 | 1.05 |
|
5yr Average Asset Turnover Ratio
|
0.68 | 1.46 | 0.05 |
|
5yr Avg Net Profit Margin
|
2.8 % | 0.71 % | 44.95 % |
|
Price to Book
|
1.17 | 0.87 | 3.05 |
|
P/E
|
121.71 | 30.79 | 161.41 |
|
5yr Avg Cash Conversion Cycle
|
211.9 Days | 123.14 Days | 49.27 Days |
|
Inventory Days
|
70.76 Days | 97.15 Days | 0.0 |
|
Days Receivable
|
147.75 Days | 158.67 Days | 49.27 Days |
|
Days Payable
|
44.01 Days | 38.34 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
1.77 | 1.63 | 7.4 |
|
5yr Avg ROCE
|
8.99 % | 10.9 % | 2.6 % |
|
5yr Avg Operating Profit Margin
|
9.07 % | 1.16 % | 44.39 % |
|
5 yr average Debt to Equity
|
0.47 | 0.76 | 0.06 |
|
5yr CAGR Net Profit
|
12.89 % | 35.25 % | -1.89 % |
|
5yr Average Return on Assets
|
1.89 % | 1.04 % | 2.09 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
63.89 % | 72.19 % | 0.03 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.63 % | 1.77 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Vilin Bio Med
|
Chandra Bhagat Pharm
|
Omkar Pharmachem
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|